Agilent Technologies Inc (A – Q1FY20) – Strong growth across all businesses.

in , on May 15, 2020

Agilent Technologies announced that it is joining forces with the Indian Institute of Technology Delhi (IIT Delhi) to promote biopharmaceutical research. Agilent and IIT Delhi signed a memorandum of understanding under which, Agilent, a leader in the biopharma space, is contributing funds to support the incubator at IIT New Delhi to support researchers at the institute establish global best practices for identifying and characterizing biopharmaceuticals. The research conducted by IIT Delhi examines and reports on the quality of biotherapeutic products for the Indian market.

Executive Summary

Financial Statements

– Income Statement and Forecast
– Balance Sheet
– Cash Flow
– Q1FY20 Results – Overview
– Q1FY20 Revenue by Region
– Q1FY20 Revenue by End-Markets
– Q1FY20 – Segment Performance
– FY20 Guidance
– Conclusion
– GAAP to Non-GAAP Reconciliation

Historical Performance

– Key Ratios
– Profitability Ratios, Asset Turnover Ratio, Growth Ratio
– Per Share Items and Key Ratios
– Key Balance Sheet and Cash Flow Items
– P/E Band

Product Performance and Key Developments

– Ownership
– Competitors
– Key Developments

Valuation and Consensus Performance

– Analyst Recommendations

Market Price Performance

Crispidea Coverage

Release Information

  • Released

    May 15, 2020

  • Last Updated

    May 18, 2020